MYND Diagnostics Commences Clinical Research on Multiple Sclerosis Biomarker Test

MYND Diagnostics Commences Clinical Research on Multiple Sclerosis Biomarker Test

MYND Life Sciences (MYND) began research on its biomarker test that aids in diagnosing multiple sclerosis. There are currently no physical indicators or lab tests that can diagnose the condition.

PDF of article